Unani treatment regimens in uterovaginal prolapse

Effect of Unani treatment regimens in uterovaginal prolapse-An Interventional Pre and Post Analysis

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/02/040110

Enrollment

Registered

2022-02-08

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N814- Uterovaginal prolapse, unspecified

Interventions

Intervention1: Unani formulation for Aabzan and Humool along with dry cupping.: Aabzan with the decoction of Gul e surkh, Izkhar and Habb-ul-aas (20gms boiled in 1 litre of water and 3 litres of water

Eligibility

Inclusion criteria

Inclusion criteria: • Parous women in the age group of 30-60 years • First & second degree uterovaginal prolapse

Exclusion criteria

Exclusion criteria: 1)Patient with procidentia, congenital elongation of cervix, huge fibroid/cyst, polyp and chronic inversion of uterus. 2) Pregnant & lactating women 3) Uncontrolled diabetes and hypertension 4)Malignancies

Design outcomes

Primary

Measure	Time frame
Changes in baden walker halfway system, vas scale, Female pelvic floor questionnaireTimepoint: Once in 2 weeks and for 8 weeks	—

Secondary

Measure	Time frame
Changes in Mass per vaginam, Urinary incontinence, Low backache, Lower abdominal discomfort and Defecation difficulties.Timepoint: Once in 15days and pre and post test	—

Countries

India

Contacts

Public ContactProf Wajeeha begum

National institute of unani medicne

drwajeehanium@gmail.com9972550185

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026